The product was not returned for evaluation.Without the return of the device, the root cause of the problem cannot be determined.Potential adverse events in the labeling with artemis neuro evacuation device include, but are not limited to, intraventricular hemorrhage, hematoma, headaches, re-bleeding, hydrocephalus, thromboembolic events, craniotomy, unintended removal of tissue leading to neurological and/or sensory deficit including death.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
|
On (b)(6) 2021, the patient underwent a micro neurosurgery procedure to treat an intracerebral hemorrhage (ich) using an artemis neuro evacuation device (artemis) and there were no reported complications during the procedure.On (b)(6) 2021, the computed tomography (ct) scan performed post mis procedure revealed a tiny amount of blood within the dependent portions of the lateral ventricles.There was rightward displacement and compression of the lateral and 3rd ventricles.It should be noted that no action was taken to treat the intraventricular hemorrhage (ivh).However, the event was considered resolved on (b)(6) 2021 and the patient was discharged to skilled nursing facility on (b)(6) 2021 for medical management.The clinical events committee (cec) adjudicated the intraventricular hemorrhage (ivh) as an adverse event related to the artemis, the index intracerebral hemorrhage (ich) and the index procedure.
|